VC-Backed Startups May Have Advantage Over Other Firms If User Fees Pass
This article was originally published in The Gray Sheet
Executive Summary
Venture capital-backed medical device developers would sustain a muted impact from having to pay user fees for 510(k)s and PMAs compared with their non-venture-backed counterparts, speakers agreed at the Medical Device Manufacturers Association annual meeting May 23 in Washington, D.C
You may also be interested in...
Kennedy To Industry: User Fees Still In Play If Third Party Sits This One Out
Industry supporters of medical device user fees are assuming a formidable challenge by linking the legislative proposal with the "Medical Device Amendments of 2001" (HR 3580), introduced by Reps. Jim Greenwood (R-Penn.) and Anna Eshoo (D-Calif.)
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.